Promethazine is an antihistamine that has been used to treat symptoms of the common cold, including coughs [1]. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms [1].
How does promethazine help with coughs?
Promethazine's effectiveness in treating coughs stems from its antihistamine and sedative properties [1][2]. By blocking histamine receptors, it can reduce the sensation of itching and irritation in the airways that may trigger a cough [1]. Its sedative effect can also help suppress the cough reflex, particularly at night, leading to better rest [2].
Are there different types of promethazine cough syrup?
Promethazine is available in various formulations, often combined with other ingredients like decongestants or expectorants in cough and cold medications [3]. For instance, it has been combined with codeine, an opioid cough suppressant, to create a potent medication for severe coughs [4].
When did promethazine cough syrup become popular?
Promethazine gained significant traction for cough treatment in the mid-20th century. Its combination with codeine, specifically, became a widely prescribed remedy [4].
What are the risks associated with promethazine cough syrup?
Promethazine can cause significant side effects, including drowsiness, dizziness, blurred vision, and dry mouth [1]. When combined with other central nervous system depressants like alcohol or opioids, its sedative effects can be dangerously amplified [5]. Due to these risks, particularly the potential for abuse and overdose when combined with codeine, its use has become more restricted [4][5]. The U.S. Food and Drug Administration (FDA) has also warned against the use of prescription combination cough and cold products containing promethazine in children under 6 years old due to serious risks [3].
What are the alternatives to promethazine for coughs?
For cough relief, numerous over-the-counter and prescription alternatives exist. These include other antihistamines, expectorants like guaifenesin to thin mucus, cough suppressants such as dextromethorphan, and inhaled corticosteroids for coughs associated with asthma [6].
What is the regulatory status of promethazine cough syrup?
Regulatory bodies have placed restrictions on promethazine cough syrups, especially those containing codeine. The FDA has highlighted the risks, particularly for young children, and recommended against their use in this age group [3]. Some countries have moved to limit or ban the over-the-counter sale of such products due to concerns about misuse and potential harm [5].
What do patients need to know about promethazine cough syrup?
Patients should be aware of the potential side effects of promethazine, especially drowsiness, which can impair driving or the operation of machinery [1]. They should also avoid alcohol and other sedatives while taking promethazine [5]. If pregnant or breastfeeding, consulting a healthcare provider before using promethazine is crucial [1]. For children, especially those under 6, promethazine-containing cough syrups are generally not recommended due to safety concerns [3].
What is the patent status of promethazine?
Promethazine is an older medication, and its original patents have long expired [7]. This means that generic versions of promethazine are available, and pharmaceutical companies do not hold exclusive rights to the drug itself. However, specific formulations or combinations involving promethazine might have had their own patent protections. Information on the patent status of specific drug formulations can be found at DrugPatentWatch.com [7].
Sources:
[1] https://www.nhs.uk/medicines/promethazine/
[2] https://www.webmd.com/drugs/2/drug-6240/promethazine-oral/details
[3] https://www.fda.gov/consumers/consumer-updates/cough-and-cold-combinations-children-what-parents-need-know
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961748/
[5] https://www.verywellhealth.com/promethazine-with-codeine-side-effects-and-risks-4164577
[6] https://www.mayoclinic.org/diseases-conditions/dry-cough/diagnosis-treatment/drc-20371825
[7] https://drugpatentwatch.com/